Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Question for the Pharma Savvy

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jun 12, 2024 8:51pm

136 Views

Post# 36086207

RE:RE:RE:RE:Question for the Pharma Savvy

It probably only matters what the BOD/Mgt votes, right? They'd far outweigh your, or anyone else's, combined votes. I agree though, even as a non-expert... would prefer at least $1B if it's a cash buyout. This is where other posters will scold me that this company is clearly worth several $B.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1